Bank of New York Mellon Corp - AVROBIO INC ownership

AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 94 filers reported holding AVROBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AVROBIO INC
ValueSharesWeighting
Q3 2023$25,854
+62.1%
16,7880.0%0.00%
Q2 2023$15,950
-5.0%
16,7880.0%0.00%
Q1 2023$16,788
+40.3%
16,7880.0%0.00%
Q4 2022$11,968
+8.8%
16,7880.0%0.00%
Q3 2022$11,000
-26.7%
16,7880.0%0.00%
Q2 2022$15,000
-92.2%
16,788
-88.5%
0.00%
Q1 2022$192,000
-66.5%
145,476
-2.3%
0.00%
Q4 2021$573,000
-29.5%
148,881
+2.4%
0.00%
Q3 2021$813,000
-22.0%
145,456
+24.2%
0.00%
Q2 2021$1,042,000
-90.4%
117,161
-86.3%
0.00%
-100.0%
Q1 2021$10,854,000
+0.7%
855,348
+10.6%
0.00%0.0%
Q4 2020$10,783,000
+9.5%
773,558
+2.3%
0.00%0.0%
Q3 2020$9,847,000
-23.5%
756,299
+2.5%
0.00%
-33.3%
Q2 2020$12,871,000
+687.2%
737,589
+602.0%
0.00%
+200.0%
Q1 2020$1,635,000
-14.9%
105,067
+10.1%
0.00%
Q4 2019$1,921,000
+54.8%
95,429
+8.6%
0.00%
Q3 2019$1,241,000
+52.5%
87,852
+75.6%
0.00%
Q2 2019$814,000
-18.4%
50,039
+10.7%
0.00%
Q1 2019$997,000
+131.3%
45,219
+74.3%
0.00%
Q4 2018$431,000
-48.6%
25,937
+60.6%
0.00%
Q3 2018$838,00016,1550.00%
Other shareholders
AVROBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,736,027$45,555,00028.05%
Aisling Capital Management LP 736,998$12,271,00012.93%
Cormorant Asset Management, LP 1,357,784$22,607,0001.84%
New Leaf Venture Partners, L.L.C. 215,550$3,589,0000.98%
Eventide Asset Management 928,891$14,901,0000.66%
EMERALD ADVISERS, LLC 380,636$6,338,0000.31%
EMERALD MUTUAL FUND ADVISERS TRUST 372,865$6,208,0000.29%
Blackstone Inc. 2,962,325$49,323,0000.28%
PFM Health Sciences, LP 241,413$4,020,0000.11%
DRIEHAUS CAPITAL MANAGEMENT LLC 143,762$2,394,0000.10%
View complete list of AVROBIO INC shareholders